Halozyme
HALO
368 hedge funds and large institutions have $5.65B invested in Halozyme in 2022 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 128 increasing their positions, 113 reducing their positions, and 26 closing their positions.
370% more call options, than puts
Call options by funds: $24.6M | Put options by funds: $5.24M
223% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 26
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
16% more funds holding
Funds holding: 318 → 368 (+50)
13% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 113
10% more capital invested
Capital invested by funds: $5.12B → $5.65B (+$529M)
0.19% less ownership
Funds ownership: 93.22% → 93.03% (-0.19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$52.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$28M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$23M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$19M |
| 5 |
Morgan Stanley
New York
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$126M |
| 2 |
BlackRock
New York
|
-$55.7M |
| 3 |
JP Morgan Chase
New York
|
-$41.1M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$33.4M |
| 5 |
Swedbank
Stockholm,
Sweden
|
-$33.2M |
HALO Hedge Fund Activity: Q2 2022 in Review
368 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2022, worth a combined $5.65B — up 10% from $5.12B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new HALO positions and 26 closed out — a net gain of 58 holders — while 128 added to existing stakes and 113 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $52.2M. The largest seller was Artisan Partners, cutting an estimated $126M.
- 368 institutional investors held Halozyme (HALO) as of Q2 2022, up from 318 in Q1 2022.
- Funds reported $5.65B of Halozyme stock for Q2 2022, up 10% quarter-over-quarter.
- 84 funds opened new Halozyme positions in Q2 2022 and 26 closed out, a net change of +58 holders.
- The largest Halozyme buyer in Q2 2022 was Victory Capital Management, an estimated $52.2M added.
- The largest Halozyme seller in Q2 2022 was Artisan Partners, an estimated $126M sold.
Based on aggregated 13F filings for Q2 2022.